An analysis of watchful waiting for clinically localized prostate cancer

Journal of Urology

Volumn 159, Issue 5, 1998, Pages 1431-1436

  Steinberg, Gary D ^a   Bales, Gregory T ^a   Brendler, Charles B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Prostate; Prostatic neoplasms

Indexed keywords

CANCER LOCALIZATION; CANCER SURVIVAL; HUMAN; LIFE EXPECTANCY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT INDICATION;

EID: 0032461041     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199805000-00003     Document Type: Review

References (38)

1. Walsh, P. C. and Donker, P. J.: Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol., 128: 492, 1982.
2. Lepor, H., Gregerman, M., Crosby, R., Mostofi, F. K. and Walsh, P. C.: Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J. Urol., 133: 207, 1985.
3. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J. Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M. and Warner, J.: Results of conservative management of clinically localized prostate cancer. New Engl. J. Med., 330: 242, 1994.
4. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. J.A.M.A., 274: 626, 1995.
5. Johansson, J. E., Holmberg, L., Johansson, S., Bergstrom, R. and Adami, H. O.: Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. J.A.M.A., 277: 467, 1997.
6. Boring, C. C., Squires, T. S. and Tong, T.: Cancer statistics. CA, 43: 7, 1993.
7. Wasson, J. H., Cushman, C. C., Bruskewitz, R. C., Littenberg, B. J., Mulley, A. G. and Wennberg, J. E.: A structured literature review of treatment for localized prostate cancer. Arch. Family Med., 2: 487, 1993.
8. Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G., Wasson, J., Roman, A. and Wennberg, J.: Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a medicare survey. Urology, 45: 1007, 1995.
9. Kabalin, J. N., McNeal, J. E., Price, H. M., Freiha, F. S. and Stamey, T. A.: Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J. Urol., 141: 1091, 1989.
10. Oesterling, J. E., Suman, V. J., Zincke, H. and Bostwick, D. G.: PSA-detected (clinical stage T1c or Bo) prostate cancer. Pathologically significant tumors. Urol. Clin. N. Amer., 20: 687, 1993.
11. Epstein, J. I., Walsh, P. C., Carmichael, M. J. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
12. Ohori, M., Wheeler, T. M., Dunn, J. K., Stamey, T. A. and Scardino, P. T.: The pathological features and prognosis of prostate cancer detectable with current diagnostics tests. J. Urol., 152: 1714, 1994.
13. Humphrey, P. A., Keetch, D. W., Smith, D. S., Shepherd, D. L. and Catalona, W. J.: Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J. Urol., 155: 816, 1996.
14. Scaletscky, R., Koch, M. O., Eckstein, C. W., Bicknell, S. L., Gray, G. F., Jr. and Smith, J. A.: Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J. Urol., 152: 129, 1994.
15. Partin, A. W., Epstein, J. I., Cho, K. R., Gittelsohn, M. A. and Walsh, P. C.: Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J. Urol., 141: 341, 1989.
16. Brendler, C. B.: Characteristics of prostate cancer found with early detection regimens. Urology, suppl., 46: 71, 1995.
17. Carter, H. B., Sauvageot, J., Walsh, P. C. and Epstein, J. I.: Prospective evaluation of men with stage Tie adenocarcinoma of the prostate. J. Urol., 157: 2206, 1997.
18. Moskovitz, B., Nitecki, S. and Levin, D. R.: Cancer of the prostate: is there a need for aggressive treatment? Urol. Int., 42: 49, 1987.
19. Goodman, C. M., Busuttil, A. and Chisholm, G. D.: Age and size and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate. Brit. J. Urol., 62: 576, 1988.
20. Whitmore, W. F., Jr., Warner, J. A. and Thompson, I. M., Jr.: Expectant management of localized prostatic cancer. CA, 67: 1091, 1991.
21. Jones, G. W.: Prospective, conservative management of localized prostate cancer. CA, suppl., 70: 307, 1992.
22. Adolfsson, J., Carstensen, J. and Lowhagen, T.: Deferred treatment in clinically localized prostatic carcinoma. Brit. J. Urol., 69: 183, 1992.
23. Johannsson, J. E., Adami, H. O., Andersson, S. O., Bergstrom, R., Holmberg, L. and Krusemo, U. B.: High 10-year survival rate in patients with early, untreated prostatic cancer. J.A.M.A., 267: 2191, 1992.
24. Klopukh, B. V., Djavan, B., Kadesky, K., Bernier, P. and Roehrborn, C. G.: High false positive rate of fine needle aspiration leads to overly optimistic assessment of outcomes of conservative treatment for localized prostate cancer. J. Urol., part 2, 153: 352A, abstract 496,1995.
25. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The John Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
26. Hanks, G. E.: Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. Acta Oncol., 30: 231, 1991.
27. Boxer, R. J., Kaufman, J. J. and Goodwin, W. E.: Radical prostatectomy for carcinoma of the prostate 1951-1976: a review of 329 patients. J. Urol., 117: 208, 1977.
28. Elder, J. S., Jewett, H. J. and Walsh, P. C.: Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J. Urol., 127: 704, 1982.
29. Quinlan, D. M., Partin, A. W. and Walsh, P. C.: Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? Urology, suppl., 46: 77, 1995.
30. Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J. and Wennberg, J. E.: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J.A.M.A., 269: 2650, 1993.
31. Beck, J. R., Kattan, M. W. and Miles, B. J.: A critique of the decision analysis for clinically localized prostate cancer. J. Urol., 152: 1894, 1994.
32. Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G., Wasson, J., Roman, A. and Wennberg, J. E.: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology, 42: 622, 1993.
33. Harris, M. J. and Thompson, I. M., Jr.: The anatomic radical perineal prostatectomy: a contemporary and anatomic approach. Urology, 485: 762, 1996.
34. Aus, G., Hugosson, J. and Norlén, L.: Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J. Urol., 154: 466, 1995.
35. Gronberg, H., Damber, L., Jonson, H. and Damber, J. E.: Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age. Urology, 49: 374, 1997.
36. Lu-Yao, G. L., McLerran, D., Wasson, J. and Wennberg, J. E.: An assessment of radical prostatectomy -time trends, geographic variation and outcomes. Prostate Patient Outcomes Research Team. J.A.M.A., 269: 2633, 1993.
37. Gerber, G. S., Thisted, R. A., Scardino, P. T., Frohmuller, H. G., Schroeder, F. H., Paulson, D. F., Middleton, A. W., Jr., Rukstalis, D. B., Smith, J. A., Jr., Schellhammer, P. F., Ohori, M. and Chodak, G. W.: Results of radical prostatectomy in men with clinically localized prostate cancer. J.A.M.A., 276: 615, 1996.
38. Chodak, G. W.: The role of watchful waiting in the management of localized prostate cancer. J. Urol., 152: 1766, 1994.